Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sentan, cilia apical structure protein (SNTN), is a calcium-binding protein localized specifically at the distal tip of motile cilia in vertebrate epithelial tissues such as the respiratory tract and oviduct[1][2][3][5]. SNTN forms a critical bridging structure between the cell membrane and peripheral singlet microtubules, contributing to the specialized narrowed and stiff apical architecture required for effective airway clearance and ovum transport[1][2]. It binds phosphatidylserine and is thought to stabilize the distinct morphology of cilia with air-respiratory functions, and is conserved among tetrapods[2][4]. SNTN is not known as a therapeutic target or receptor, but is relevant in structural studies of cilia and some ciliopathies such as primary ciliary dyskinesia[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sentan, cilia apical structure protein (SNTN).